
cached image
Sunhee C. Lee, MD - US grants
Affiliations: | Pathology | Albert Einstein College of Medicine, New York, New York, United States |
Area:
AIDS, Multiple Sclerosis, Stroke, Chemokines, Cytokines, ReceptorsWebsite:
http://www.einstein.yu.edu/pathology/faculty_Profile.asp?personID=3814We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the NIH Research Portfolio Online Reporting Tools and the NSF Award Database.The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please sign in and mark grants as correct or incorrect matches.
High-probability grants
According to our matching algorithm, Sunhee C. Lee is the likely recipient of the following grants.Years | Recipients | Code | Title / Keywords | Matching score |
---|---|---|---|---|
2001 — 2006 | Lee, Sunhee C | R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
@ Albert Einstein Col of Med Yeshiva Univ Microglia are main targets of HIV-1 in the CNS, and neurological disease (HAD/HIVE) occurs as a result of interaction between HIV-1 and glial cells leading to neuronal apoptosis. Studies from the previous funding period have demonstrated that in the CNS of HIVE and in primary cultures of human glia, activated microglia express IL-1 which induces astrocyte TNFalpha and INOS, resulting in neuronal apoptosis. IFNbeta downregulates inflammatory activation of glial cells and induces anti-HIV-1 beta-chemokines (RANTES, MIP-1beta and MIP-1alpha), suggesting a role for IFNbeta as a therapy for HIVE. In addition to IFNbeta, a number of macrophage to the inhibitory effect of exogenous beta-chemokines diminishes under these conditions. Furthermore, beta-chemokines are induces in HIV-1 infected microglia by mechanisms linked to viral replication and MAP kinases play differential roles in IFNbeta- and HIV-induced beta-chemokine expression. Cytokine-induces apoptosis of primary human neurons occurs via caspases-dependent mechanisms and IFNbeta exhibits an anti-apoptotic property in this system. Based on these findings, we propose the following specific aims. Specific Aim 1: To determine the role of macrophage activators in HIV-1 infection of microglia. Specific Aim 2: To determine the mechanism of RANTES induction in human glia. Specific Aim 3: To determine the role of IFNbeta/chemokines in cytokine- or HIV-mediated neurotoxicity and to examine the role of caspases in these processes. |
0.964 |
2004 — 2008 | Lee, Sunhee C | P01Activity Code Description: For the support of a broadly based, multidisciplinary, often long-term research program which has a specific major objective or a basic theme. A program project generally involves the organized efforts of relatively large groups, members of which are conducting research projects designed to elucidate the various aspects or components of this objective. Each research project is usually under the leadership of an established investigator. The grant can provide support for certain basic resources used by these groups in the program, including clinical components, the sharing of which facilitates the total research effort. A program project is directed toward a range of problems having a central research focus, in contrast to the usually narrower thrust of the traditional research project. Each project supported through this mechanism should contribute or be directly related to the common theme of the total research effort. These scientifically meritorious projects should demonstrate an essential element of unity and interdependence, i.e., a system of research activities and projects directed toward a well-defined research program goal. |
@ Albert Einstein Col of Med Yeshiva Univ The major purpose of the Neuropathology Core (NP Core) is to perform diagnostic neuropathologic evaluations on brains of participants in the Einstein Aging Study (EAS). To accomplish this aim, the NP Core integrates its activities with the Einstein/Montefiore Pathology Departmental on-call service for harvesting brains of subjects enrolled in the EAS in a timely fashion and according to protocol. The NP Core uses standardized dissection and processing procedures and collects neuropathologic data from all brains with the following methods: a. Gross examination with digital photography, b. Assessment of histopathology, c. Lesion counts with thioflavin-S fluorescent microscopy, and d. PHF-tau immunostained sections for staging Alzheimer type pathology. For cases with vascular lesions, gross lesions are photographed and the number, type and distribution of lesions are documented. In cases with either neuronal loss or Lewy bodies in the substantia nigra, multiple sections are immunostained with antibodies to synuclein. The amygdala of all AD cases is screened for synuclein immunoreactive Lewy bodies and for 4-repeat tau immunoreactive argyrophilic grains. When detected, the density of Lewy bodies is determined in multiple cortical areas and the amygdala. Non-Alzheimer degenerative dementias are characterized with immunocytochemistry and antibodies to neurofilament, ubiquitin and PHF-tau. Microglial immunohistochemistry is also routinely used to demonstrate diverse pathologies. The NP Core provides fixed and frozen brain samples to Project 3 for immunocytochemical, image analytical and enzyme linked immunosorbent assays. Tissue is provided to other qualified investigators with approval of the Administrative Core. The NP Core determines apolipoprotein-E genotypes and TAU haplotypes and banks DNA and RNA from brain tissue. Tissue quality is also assessed with pH and western blots for HSP70. Tissue samples, slides and paraffin blocks are banked for future studies. Reports are provided to the Administrative Core and data to the Statistical Core using standardized protocols and procedures. |
0.964 |
2007 — 2011 | Lee, Sunhee C | R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
@ Albert Einstein College of Medicine DESCRIPTION (provided by applicant): Toll-like receptors (TLRs) have emerged as crucial receptors on immune cells that mediate innate immunity against pathogens. TLRs signal through MyD88, an adaptor molecule containing the TLR-IL-1 receptor domain (TIR), to activate NF-KB and MAP kinases. Of the 11 members of the TLR family, TLR3 and TLR4 also signal through another TIR protein called TRIP that activates the key transcription factor IRF3 resulting in the production of IFNb. This sets off the induction of numerous IFN-stimulated genes, culminating in anti- viral immunity. TLR ligands and IL-1 are powerful activators of microglia and astrocytes modulating inflammatory and antiviral response genes, yet their role in anti-viral immunity and the signal transduction pathways involved are not known. We made a novel observation that the TLR3 ligand, synthetic dsRNA, poly-riboinosinic poly-ribocytidylic acid (PIC), limits HIV replication in microglia and astrocytes, whereas IL- 1, which also activates IRF3 and the arrays of genes similar to PIC, does not. In this competing renewal, we propose to study dsRNA signaling in primary human glia with the hypothesis that during HIV infection, TLR3 is upregulated but no effective dsRNA signaling occurs due to lack of available ligands and/or inhibition by HIV. We further propose that PIC can be used to boost antiviral immunity in vivo. Three specific aims are proposed. Specific Aim 1 is to elucidate TLRS signal transduction pathways in human astrocytes and microglia with respect to the mechanisms that lead to innate anti-viral immune response. Specific Aim 2 is to determine PIC-induced modulation of HIV replication, glial inflammatory activation and neurotoxicity in human glia and neurons in vitro. Specific Aim 3 is to characterize PIC- and HIV-induced gene expression and activity in vivo. We will study the efficacy of PIC to induce TLR3 and antiviral molecules in an HIV transgenic mouse model. In addition, the expression of TLRs and innate immune molecules in the brains of HIV encephalitis will be determined. These studies will provide molecular insights into the potential role of PIC and its downstream effectors such as indoleamine 2, 3-dioxygenase in modulating various aspects of HIV neuropathogenesis. These studies are relevant to public health because they will provide crucial information regarding how human brain cells fight against viral infections, and furthermore, they may lead to a new therapy for neuroAIDS. Since the brain harbors long-lived HIV- infected cells such as microglia, eradication of HIV from this site could also lead to cure of HIV/AID. |
1 |
2016 — 2019 | Lee, Sunhee C | P01Activity Code Description: For the support of a broadly based, multidisciplinary, often long-term research program which has a specific major objective or a basic theme. A program project generally involves the organized efforts of relatively large groups, members of which are conducting research projects designed to elucidate the various aspects or components of this objective. Each research project is usually under the leadership of an established investigator. The grant can provide support for certain basic resources used by these groups in the program, including clinical components, the sharing of which facilitates the total research effort. A program project is directed toward a range of problems having a central research focus, in contrast to the usually narrower thrust of the traditional research project. Each project supported through this mechanism should contribute or be directly related to the common theme of the total research effort. These scientifically meritorious projects should demonstrate an essential element of unity and interdependence, i.e., a system of research activities and projects directed toward a well-defined research program goal. |
@ Albert Einstein College of Medicine, Inc PROJECT SUMMARY/ABSTRACT The major purpose of the Neuropathology Core (NP Core) is to perform diagnostic neuropathologic evaluations on brains of participants in the Einstein Aging Study (EAS) and to support research for the Projects. The NP Core integrates its activities with the Montefiore Pathology Departmental on-call service for harvesting brains in a timely fashion of subjects enrolled in the EAS. The NP Core uses standardized dissection and processing procedures and collects neuropathologic data from all brains. Diagnostic reports are communicated with key personnel of the EAS as soon as they are completed by electronic communication. Clinicopathologic correlation analyses are discussed in person at annual meetings. The Specific Aims of the NP Core are as follows: Aim 1. Perform brain autopsies and prepare tissue for transport from Montefiore Hospital to Mayo Clinic. Aim 2. Diagnostic neuropathology using a standardized and systematic approach that has been used over the life of the EAS, permitting use of the entire autopsy cohort for clinicopathologic correlative studies and for use in research studies. Aim 3. Data entry from neuropathology report. A written report is generate in text form for easy communication with clinicians and family members, but a digital form is created for long-term storage and linkage to NP Core databases - one specific to the Einstein Aging Study and the other a part of the Mayo Clinic brain bank for neurodegenerative disorders, which is linked to tissue inventory, ancillary data (e.g., genetic data), as well as quantitative pathology and demographics, which permits pooling of Einstein Aging Study cases into larger clinicopathologic studies. Neuropathologic data are transferred to Biostatistics and Data Management Core. Aim 4. Conduct exploratory studies in support of Projects. As pain and stress measures are associated with reduced hippocampal volume (Project 1), we assess a range of cellular pathologies in the hippocampus with respect to subsectors of Ammon's horn. Cardiac autonomic abnormalities leading to heart rate variability are linked to risk for cognitive impairment and correlate with white matter hyperintensities (Project 2). The NP Core assesses of cerebrovascular pathology and measures of microvascular and white matter pathology to explore possible pathologic relationships to cardiovascular and autonomic measures. Aim 5. Sharing of tissue. The Neuropathology Core banks fixed and frozen brain tissue, as well as paraffin blocks on all cases. DNA and RNA are extracted from tissue, and they are also banked. Fixed and frozen tissue, as well as DNA, slides and paraffin blocks are available for sharing with qualified investigators with approval of the Administrative Core. |
1 |